+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019

  • ID: 4898206
  • Report
  • December 2019
  • Region: Global
  • 197 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Admedus Ltd
  • Clemson University
  • Edwards Lifesciences Corp
  • Mayo Clinic
  • SAS Cormove
  • University of Cambridge
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019“ provides an overview of Transcatheter Aortic Valves Implantation (TAVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Aortic Valves Implantation (TAVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Aortic Valves Implantation (TAVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valves Implantation (TAVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valves Implantation (TAVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Admedus Ltd
  • Clemson University
  • Edwards Lifesciences Corp
  • Mayo Clinic
  • SAS Cormove
  • University of Cambridge

1 Introduction
1.1 Transcatheter Aortic Valve Implantation (TAVI) Overview
2 Products under Development
2.1 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
2.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
2.3 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
2.4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
2.5 Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
3 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products under Development by Companies
3.1 Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
3.2 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
4 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview
4.1 Admedus Ltd Company Overview
4.1.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.2 Aegis Surgical Limited Company Overview
4.2.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
4.3 AorTx, Inc. Company Overview
4.3.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.4 Arbor Surgical Technologies, Inc. Company Overview
4.4.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.5 Boston Scientific Corp Company Overview
4.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.6 Carena Healthcare Ltd Company Overview
4.6.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.7 Clemson University Company Overview
4.7.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
4.8 Colibri Heart Valve LLC Company Overview
4.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
4.9 Daidalos Solutions BV Company Overview
4.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
4.10 Direct Flow Medical Inc (Inactive) Company Overview
4.10.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.11 DSM Dyneema BV Company Overview
4.11.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
4.12 Dura LLC Company Overview
4.12.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
4.13 Edwards Lifesciences Corp Company Overview
4.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
4.14 Foldax Inc Company Overview
4.14.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
4.15 HLT, Inc. Company Overview
4.15.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.16 JC Medical, Inc. Company Overview
4.16.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.17 JenaValve Technology GmbH Company Overview
4.17.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.18 Mayo Clinic Company Overview
4.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
4.19 Medtronic plc Company Overview
4.19.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.20 Meril Life Sciences Pvt Ltd Company Overview
4.20.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments
5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.2 Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
5.3 Nov 07, 2019: Edwards Lifesciences gets approval for SAPIEN 3 TAVI valve in Europe
5.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
5.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Table 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
Table 6: Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 8: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Transcatheter Aortic Valve Replacement Device - Product Status
Table 10: Transcatheter Aortic Valve Replacement Device - Product Description
Table 11: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: pTAo-TAVR - Product Status
Table 13: pTAo-TAVR - Product Description
Table 14: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: AorTx Valve - Product Status
Table 16: AorTx Valve - Product Description
Table 17: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Trilogy Aortic Valve System - Product Status
Table 19: Trilogy Aortic Valve System - Product Description
Table 20: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Gen 4 Lotus Valve System - Product Status
Table 22: Gen 4 Lotus Valve System - Product Description
Table 23: Lotus Edge Sheath 15F - Product Status
Table 24: Lotus Edge Sheath 15F - Product Description
Table 25: LOTUS Edge Valve Expanded Sizes - Product Status
Table 26: LOTUS Edge Valve Expanded Sizes - Product Description
Table 27: Lotus Edge Valve System - Product Status
Table 28: Lotus Edge Valve System - Product Description
Table 29: LOTUS Mantra - Product Status
Table 30: LOTUS Mantra - Product Description
Table 31: Lotus Valve System - 21 mm - Product Status
Table 32: Lotus Valve System - 21 mm - Product Description
Table 33: Lotus Valve System - 23 mm - Product Status
Table 34: Lotus Valve System - 23 mm - Product Description
Table 35: Lotus Valve System - 25 mm - Product Status
Table 36: Lotus Valve System - 25 mm - Product Description
Table 37: Lotus Valve System - 27 mm - Product Status
Table 38: Lotus Valve System - 27 mm - Product Description
Table 39: Lotus Valve System - 29 mm - Product Status
Table 40: Lotus Valve System - 29 mm - Product Description
Table 41: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 42: Lotus Valve System - 23 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 43: Lotus Valve System - 23 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 44: Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 45: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 46: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 47: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 48: Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 49: Lotus Valve System - 27 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 50: Lotus Valve System - 27 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 51: Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 52: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 53: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 54: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 55: Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 56: Lotus Valve System - 25 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 57: Lotus Valve System - 25 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 58: Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 59: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 60: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 61: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 62: Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 63: Lotus Valve System - 21 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
List of Figures
Figure 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Figure 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Admedus Ltd
  • Aegis Surgical Limited
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Boston Scientific Corp
  • Carena Healthcare Ltd
  • Clemson University
  • Colibri Heart Valve LLC
  • Daidalos Solutions BV
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Foldax Inc
  • HLT, Inc.
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Mayo Clinic
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • MicroPort Scientific Corp
  • PolyNova Cardiovascular Inc
  • RegenaGraft
  • ReValve Med Inc
  • SAS Cormove
  • St. Jude Medical LLC
  • Stony Brook University
  • Symetis SA
  • Thubrikar Aortic Valve, Inc.
  • University College London
  • University of British Columbia
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • Vascular Concepts Ltd
  • Venus MedTech
  • Xeltis AG
Note: Product cover images may vary from those shown